Context Therapeutics Inc.
CNTXNasdaqCIK 1842952HealthcareFiscal year ends Dec 31
Reports and events: 88 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0516:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-053378 |
| 2026-08-0516:09 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-053347 |
| 2026-07-3116:08 ET | 8-K | 3.01 Delisting notice | 0001628280-26-051399 |
| 2026-06-2616:07 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-045744 |
| 2026-06-1509:18 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-043042 |
| 2026-05-1806:47 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-035793 |
| 2026-05-0616:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-031267 |
| 2026-05-0116:07 ET | 8-K | 8.01 Other events | 0001628280-26-029323 |
| 2026-04-2816:12 ET | DEF 14A | Proxy statementPeriod 2026-04-28 | 0001628280-26-027928 |
| 2026-04-0207:41 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-022931 |
| 2026-03-2316:22 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-020517 |
| 2026-03-2316:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-020498 |
| 2026-03-1316:09 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-017691 |
| 2026-02-2716:11 ET | 8-K | 8.01 Other events | 0001628280-26-012813 |
| 2026-01-0807:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-001275 |
| 2025-11-0516:21 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-049604 |
| 2025-11-0516:08 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-049533 |
| 2025-10-2416:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-046258 |
| 2025-10-2016:04 ET | 8-K | 8.01 Other events | 0001628280-25-045513 |
| 2025-09-0207:32 ET | 8-K | 3.01 Delisting notice | 0001842952-25-000085 |
| 2025-08-0616:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001842952-25-000081 |
| 2025-06-1217:14 ET | 8-K | 5.07 Shareholder vote results | 0001842952-25-000072 |
| 2025-06-0207:34 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-25-000051 |
| 2025-05-0716:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001842952-25-000048 |
| 2025-04-1516:05 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001842952-25-000042 |
| 2025-04-0907:33 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-25-000037 |
| 2025-03-2016:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001842952-25-000028 |
| 2025-02-2816:06 ET | 8-K | 3.01 Delisting notice | 0001842952-25-000024 |
| 2025-01-1417:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-25-000006 |
| 2025-01-1307:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-25-000003 |
| 2024-12-2309:26 ET | 8-K | 8.01 Other events | 0001842952-24-000087 |
| 2024-12-0216:21 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-049570 |
| 2024-11-0616:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001842952-24-000085 |
| 2024-09-2307:33 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-24-000083 |
| 2024-09-1716:22 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001842952-24-000081 |
| 2024-09-0407:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-24-000070 |
| 2024-08-0716:07 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001842952-24-000065 |
| 2024-07-2416:55 ET | DEF 14A | Proxy statementPeriod 2024-09-17 | 0001842952-24-000055 |
| 2024-07-1007:33 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-24-000050 |
| 2024-06-1407:34 ET | 8-K | 5.07 Shareholder vote results | 0001842952-24-000041 |
| 2024-05-0816:03 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001842952-24-000035 |
| 2024-05-0207:37 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-24-000033 |
| 2024-04-2616:10 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0001842952-24-000027 |
| 2024-04-0107:32 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-24-000022 |
| 2024-03-2107:36 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001842952-24-000011 |
| 2024-03-2107:31 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001842952-24-000010 |
| 2024-03-0607:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-24-000005 |
| 2023-11-0916:04 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001842952-23-000085 |
| 2023-10-3109:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-23-000082 |
| 2023-08-0916:04 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001842952-23-000078 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.